Liao Wenbin, Huang Nick, Yu Jingxia, Jares Alexander, Yang Jianchang, Zieve Gary, Avila Cecilia, Jiang Xun, Zhang Xiao-Bing, Ma Yupo
Departments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA
Departments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Stem Cells Transl Med. 2015 Jul;4(7):755-63. doi: 10.5966/sctm.2014-0289. Epub 2015 May 13.
: Cellular reprogramming or conversion is a promising strategy to generate desired stem cell types from somatic cells. Neural stem cells (NSCs) have the potential to regenerate central nervous system tissue and repair damage in response to injury. However, NSCs are difficult to isolate from human tissues and expand in sufficient quantities for therapy. Here, we report a method to generate neural stem cells from cord blood CD34-positive cells by ectopic expression of OCT4 in a feeder-free system. The induced cells (iNSCs) show a characteristic NSC-like morphology and can be expanded in vitro for more than 20 passages. In addition, the iNSCs are positive for neural stem cell-specific markers such as Nestin and Musashi-1 and are similar in gene expression patterns to a human neural stem cell line. The iNSCs express distinct transcriptional factors for forebrain, hindbrain, and spinal cord regions. Upon differentiation, the iNSCs are able to commit into multilineage mature neural cells. Following in vivo introduction into NOD/SCID mice, iNSCs can survive and differentiate in the mouse brain 3 months post-transplantation. Alternatively, we were also able to derive iNSCs with an episomal vector expressing OCT4. Our results suggest a novel, efficient approach to generate neural precursor cells that can be potentially used in drug discovery or regenerative medicine for neurological disease and injury.
This study describes a novel method to generate expandable induced neural stem cells from human cord blood cells in a feeder-free system by a single factor, OCT4. The data are promising for future applications that require the generation of large amounts of autologous neural stem cells in disease modeling and regenerative medicine.
细胞重编程或转化是一种从体细胞生成所需干细胞类型的有前景的策略。神经干细胞(NSCs)有潜力再生中枢神经系统组织并修复损伤。然而,从人体组织中分离神经干细胞并大量扩增用于治疗很困难。在此,我们报告一种在无饲养层系统中通过异位表达OCT4从脐血CD34阳性细胞生成神经干细胞的方法。诱导产生的细胞(iNSCs)呈现出典型的神经干细胞样形态,并且能在体外扩增超过20代。此外,iNSCs对神经干细胞特异性标志物如巢蛋白(Nestin)和神经胶质瘤相关癌基因1(Musashi-1)呈阳性,并且在基因表达模式上与一种人类神经干细胞系相似。iNSCs表达前脑、后脑和脊髓区域不同的转录因子。在分化时,iNSCs能够分化为多谱系成熟神经细胞。在体内导入NOD/SCID小鼠后,iNSCs在移植后3个月能在小鼠脑内存活并分化。另外,我们也能够用表达OCT4的附加型载体获得iNSCs。我们的结果提示一种新的、有效的方法来生成神经前体细胞,其可能用于药物发现或神经疾病和损伤的再生医学。
本研究描述了一种在无饲养层系统中通过单一因子OCT4从人脐血细胞生成可扩增的诱导神经干细胞的新方法。这些数据对于未来在疾病建模和再生医学中需要大量自体神经干细胞生成的应用很有前景。